David Shaw’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,166,751
Closed -$11.6M 5771
2022
Q2
$11.6M Hold
1,166,751
0.01% 1264
2022
Q1
$11.6M Buy
1,166,751
+169,273
+17% +$1.67M 0.01% 1478
2021
Q4
$9.81M Buy
997,478
+255,233
+34% +$2.51M 0.01% 1683
2021
Q3
$7.3M Buy
742,245
+475,629
+178% +$4.64M 0.01% 1774
2021
Q2
$2.61M Buy
+266,616
New +$2.6M ﹤0.01% 2660

David Shaw's ISLE Position: Q3 2022 in Review

David Shaw sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 1,166,751 shares — an estimated $11.6M sold.

David Shaw first reported a position in ISLE in Q2 2021 and held it in 5 quarters. The position peaked at $11.6M in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • David Shaw reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 1,166,751 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $11.6M.
  • David Shaw first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2021 and held it in 5 quarters.
  • David Shaw's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $11.6M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.